Page 39 - 《中国药房》2023年8期
P. 39

肝宝胶囊对非酒精性脂肪性肝病模型大鼠肠黏膜屏障和肠道菌

          群的影响
                        Δ

                                  3
                          2
                                           3
                 1*
                                                   1 #
          范 兴 ,何 艳 ,杨成梓 ,林雅婷 ,黄德福 (1.福建医科大学孟超肝胆医院药学部,福州 350025;2.浙大
          城市学院医学院,杭州 310015;3.福建中医药大学药学院,福州 350122)
          中图分类号  R965      文献标志码  A      文章编号  1001-0408(2023)08-0929-06
          DOI  10.6039/j.issn.1001-0408.2023.08.07

          摘  要  目的  研究肝宝胶囊对非酒精性脂肪性肝病(NAFLD)模型大鼠肠黏膜屏障和肠道菌群的影响,探讨其防治NAFLD的机
          制。方法  将26只SD大鼠随机选择8只作为空白组,给予普通饲料喂养,剩余18只喂食高脂饲料建立NAFLD模型(2只用于成模
          检查),造模成功后,按随机数字表法分为模型组和肝宝组,每组8只。肝宝组大鼠灌胃肝宝胶囊溶液(1 440 mg/kg),空白组与模
          型组大鼠灌胃等体积蒸馏水,每日1次,连续5周。采用全自动生化分析仪检测大鼠血清中丙氨酸转氨酶(ALT)、天冬氨酸转氨酶
         (AST)和甘油三酯(TG)含量;酶联免疫吸附测定法检测大鼠血清中脂多糖、肿瘤坏死因子α(TNF-α)、白细胞介素6(IL-6)、IL-1β
          含量;苏木精-伊红染色法观察大鼠肝脏和回肠组织病理形态;免疫组化法测定回肠组织中闭合蛋白(Occludin)和闭锁小带蛋白-1
         (ZO-1)的表达;16S核糖体RNA基因测序技术测定大鼠肠道菌群。结果  与模型组比较,肝宝组大鼠血清中ALT、AST、TG、脂多
          糖、TNF-α、IL-6与IL-1β含量均显著降低(P<0.01),肝脏和回肠组织病变程度均明显改善,回肠组织中Occludin和ZO-1蛋白表达
          水平均显著升高(P<0.01)。肠道菌群分析显示,与模型组比较,肝宝胶囊能提高大鼠肠道菌群的丰富度和多样性;在门水平上,
          肝宝胶囊能显著升高拟杆菌门相对丰度,降低厚壁菌门相对丰度以及二者相对丰度比值(P<0.01);在属水平上,肝宝胶囊能显著
          升高乳杆菌属、布劳特氏菌属、拟杆菌属和阿克曼菌属的相对丰度,显著降低普雷沃氏菌属、苏黎世杆菌属、魏斯氏菌属、SMB53和
          脱硫弧菌属的相对丰度(P<0.05或P<0.01)。各组大鼠肠道菌群间均有差异物种。结论  肝宝胶囊可能通过保护肠黏膜屏障功
          能和调节肠道益生菌/有害菌结构来改善NAFLD。
          关键词  肝宝胶囊;非酒精性脂肪性肝病;肠黏膜屏障;肠道菌群;16S核糖体RNA

          Effects  of  Ganbao  capsules  on  intestinal  mucosal  barrier  and  gut  microbiota  in  rats  with  non-alcoholic
          fatty liver disease
          FAN Xing ,HE Yan ,YANG Chengzi ,LIN Yating ,HUANG Defu (1.  Dept.  of  Pharmacy,  Mengchao
                                              3
                   1
                             2
                                                           3
                                                                          1
          Hepatobiliary  Hospital  of  Fujian  Medical  University,  Fuzhou  350025,  China;2.  School  of  Medicine,  Zhejiang
          University  City  College,  Hangzhou  310025,  China;3.  Pharmacy  College,  Fujian  University  of  Traditional
          Chinese Medicine, Fuzhou 350122, China)
          ABSTRACT   OBJECTIVE  To study the effects of Ganbao capsules on intestinal mucosal barrier and gut microbiota in rats with
          non-alcoholic  fatty  liver  disease (NAFLD),  and  to  explore  its  mechanism  of  prevention  and  treatment  of  NAFLD.  METHODS
          Eight  of  26  SD  rats  were  randomly  selected  as  blank  group  and  fed  with  ordinary  diet,  and  the  remaining  18  rats  were  fed  with
          high  diet  to  establish  NAFLD  model (2  for  modeling  inspection);  after  successful  modeling,  they  were  divided  into  model  group
          and Ganbao group, with 8 rats in each group. Ganbao group were given Ganbao capsules solution (1 440 mg/kg) intragastrically,
          and the blank group and model group were given the constant volume of distilled water intragastrically, once a day, for consecutive
          5 weeks. The contents of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and triglyceride (TG) in serum of rats
          were  detected  by  automatic  analyzer;  the  contents  of  lipopolysaccharide,  tumor  necrosis  factor-α (TNF-α),  interleukin-6 (IL-6)
          and IL-1β in serum of rats were detected by enzyme-linked immunosorbent assay. The pathological morphology of liver and ileum
          tissues  were  observed  by  HE  staining,  the  expressions  of  Occludin  and  zonula  occludens-1  (ZO-1)  were  detected  by
          immunohistochemistry  method,  and  the  intestinal  flora  were  detected  by  16S  ribosomal  RNA  gene  sequencing  technology.
          RESULTS  Compared with the model group, the serum contents of ALT, AST, TG, lipopolysaccharide, TNF-α, IL-6 and IL-1β
                                                             in  Ganbao  group  were  decreased  significantly (P<0.01),  the
             Δ 基金项目 福建省自然科学基金资助项目(No.2021J011296);福          pathological  changes  of  liver  and  ileum  tissues  were  improved
          建省中医重点专科建设项目中药制剂室(No. 闽卫中医函〔2019〕262
                                                             significantly,  and  the  expressions  of  Occludin  and  ZO-1  were
          号);福州市科技计划项目(No.2020-WS-85)
                                                             increased   significantly  (P<0.01).   Intestinal   microbiota
             *第一作者 主管中药师,硕士。研究方向:中药制剂研发。
          E-mail:FXTCM2007@126.com                           analysis revealed that compared with the model group, Ganbao
             # 通信作者 副主任药师。研究方向:医院药学管理、中药药理。                  capsules  could  recover  the  abundance  and  diversity  of  the  gut
          E-mail:hdf8833@126.com                             microbiota in rats. At the phylum level, Ganbao capsules could


          中国药房  2023年第34卷第8期                                                 China Pharmacy  2023 Vol. 34  No. 8    · 929 ·
   34   35   36   37   38   39   40   41   42   43   44